Introduction – Addressing Core Digestive Disorders: Hyperacidity, Slow Bowel Motility, and Epigastric Distension
For primary care physicians, gastroenterologists, and patients suffering from dyspepsia (indigestion), epigastric pain, bloating, belching, heartburn, and constipation (infrequent bowel movements, hard stools), conventional antacids (aluminum hydroxide, magnesium hydroxide, calcium carbonate) neutralize gastric acid but do not address the constipation or promote bowel movement. Single-agent laxatives (senna, bisacodyl, lactulose) may cause abdominal cramps and do not neutralize acid. Rhubarb sodium bicarbonate tablets – a compound formulation containing rhubarb (Rheum officinale or Rheum palmatum), sodium bicarbonate (NaHCO₃), and peppermint oil (Mentha piperita) – directly address these concurrent symptoms of hyperacidity and constipation. Rhubarb acts as a mild laxative (stimulant laxative, due to anthraquinone glycosides (sennosides, rhein)), promoting bowel movement and relieving constipation. Sodium bicarbonate is an antacid that neutralizes gastric acid (provides rapid relief of heartburn, acid indigestion, sour stomach). Peppermint oil has carminative (relieves flatulence, bloating) and antispasmodic (soothes gastrointestinal smooth muscle) properties. This combination is used for symptoms of functional dyspepsia, gastritis, epigastric distension, and occasional constipation. Typical tablet composition: Rhubarb 0.15g, Sodium Bicarbonate 0.15g, Peppermint Oil 0.001ml (per tablet). As the prevalence of functional gastrointestinal disorders (FGIDs) (e.g., dyspepsia (10-20% of adults), chronic constipation (15% of adults)) remains high, and patients self-medicate with OTC (over-the-counter) digestive aids, the market for rhubarb antacid laxatives across hospitals, clinics, and other settings is steadily maintained. This deep-dive analysis integrates QYResearch’s latest forecasts (2026–2032), formulation type segmentation, and clinical use insights.
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Rhubarb Sodium Bicarbonate Tablets – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Rhubarb Sodium Bicarbonate Tablets market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Rhubarb Sodium Bicarbonate Tablets was estimated to be worth USmillionin2025andisprojectedtoreachUSmillionin2025andisprojectedtoreachUS million, growing at a CAGR of % from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5974999/rhubarb-sodium-bicarbonate-tablets
Core Keywords (Embedded Throughout)
- Rhubarb sodium bicarbonate tablets
- Compound antacid
- Stimulant laxative
- Peppermint oil
- Dyspepsia relief
Market Segmentation by Formulation and Healthcare Setting
The rhubarb sodium bicarbonate tablets market is segmented below by both composition (type) and point-of-care location (application). Understanding this matrix is essential for pharmaceutical manufacturers targeting specific digestive symptom clusters (hyperacidity + constipation) and dispensing channels.
By Type (Formulation / Ingredients):
- Compound Rhubarb Sodium Bicarbonate Tablets (specific composition: Rhubarb 0.15g, Sodium Bicarbonate 0.15g, Peppermint Oil 0.001ml per tablet. May also contain other inactive ingredients (corn starch, magnesium stearate). Typical dosage: 2-4 tablets three times daily after meals)
- Other (variations in rhubarb content or additional ingredients)
By Application:
- Hospital (inpatient: functional dyspepsia, gastritis, chronic constipation; dispensed by hospital pharmacy)
- Clinic (outpatient: gastroenterology clinics, primary care; prescribed for functional dyspepsia)
- Others (self-medication, OTC (over-the-counter) purchase; home use)
Industry Stratification: Mechanism of Action of Active Ingredients
Rhubarb (Rheum officinale):
- Contains anthraquinone glycosides (sennosides A-B, rhein, emodin, aloe-emodin, chrysophanol, physcion).
- Mechanism: proanthocyanidins and sennosides are hydrolyzed by gut bacteria to active metabolites (rhein anthrone). Stimulates colonic peristalsis (inhibits Na+/K+ ATPase, increases water and electrolyte secretion).
- Onset: 6-12 hours.
- Caution: long-term use may cause melanosis coli, electrolyte imbalance, dependence.
Sodium bicarbonate:
- Neutralizes gastric acid (HCl → NaCl + H₂O + CO₂).
- Rapid onset (minutes).
- Caution: may cause belching (CO₂), metabolic alkalosis if high doses or renal impairment, sodium load.
Peppermint oil:
- Carminative (relieves flatulence).
- Antispasmodic (smooth muscle relaxant) in GI tract (reduces cramping).
- Enteric-coated to prevent heartburn? not in this formulation.
Recent 6-Month Industry Data (September 2025 – February 2026)
- Rhubarb Antacid Market: exists mainly in Asia (China, Japan, Korea) and as TCM (Traditional Chinese Medicine) product.
- Dyspepsia Prevalence (November 2025): 15-20% of adults.
- OTC Digestive Aids (December 2025): growth with self-care.
- Innovation data (Q4 2025): generic rhubarb sodium bicarbonate tablets (0.15g/0.15g) available.
Typical User Case – Functional Dyspepsia & Constipation
A patient with epigastric pain (after meals), bloating, belching, and occasional constipation diagnosed with functional dyspepsia with slow transit.
Prescribed: rhubarb sodium bicarbonate tablets, 2 tablets three times daily after meals.
Mechanism: sodium bicarbonate neutralizes acid (relieves epigastric pain, heartburn); rhubarb stimulates bowel movement (relieves constipation); peppermint oil reduces bloating.
Technical Difficulties and Current Solutions
Despite safety, rhubarb sodium bicarbonate tablets use faces four persistent clinical considerations:
- Chronic use – laxative dependence. Long-term use discouraged; treat underlying cause.
- Sodium load (bicarbonate) in hypertension, heart failure, renal disease. Caution, consider alternative antacids.
- Interaction with other medications (rhubarb may reduce absorption of some drugs). Separate administration.
- Melena-like discoloration (rhubarb red pigmentation). May be mistaken for GI bleeding; educate patient.
Exclusive Industry Observation – The Rhubarb Sodium Bicarbonate Tablet Market by Region
Based on QYResearch’s interviews with 93 gastroenterologists and pharmacists (October 2025 – January 2026), China primary market (TCM acceptance); other Asian countries; limited in West.
China – 80% of demand (over-the-counter, hospital).
Other Asia – 15%.
For suppliers, key strategy: focus on China market (OTC, hospital); combination laxative-antacid positioning; patient education on short-term use.
Complete Market Segmentation (as per original data)
The Rhubarb Sodium Bicarbonate Tablets market is segmented as below:
Major Players:
Henan Furentang Pharmaceutical Co., Ltd., Henan Hezhi Pharmaceutical Technology Co., Ltd., China Resources Shuanghe Pharmaceutical Co., Ltd., Zhengzhou Baolong Pharmaceutical Co., Ltd., Sichuan Jinyaoshi Pharmaceutical Co., Ltd., Sichuan Deyuan Pharmaceutical Group Co., Ltd., Ankang Zhengda Pharmaceutical Co., Ltd., Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd., Chengdu First Pharmaceutical Co., Ltd., Chifeng Mengxin Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd., Furen Pharmaceutical Group Co., Ltd., Guangdong Nanguo Pharmaceutical Co., Ltd.
Segment by Type:
Compound Rhubarb Sodium Bicarbonate Tablets, Rhubarb 0.15g, Sodium Bicarbonate 0.15g, Peppermint Oil 0.001ml
Segment by Application:
Hospital, Clinic, Others
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
